The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

News provided by

Dec 15, 2014, 01:18 ET

LONDON, Dec. 15, 2014 /PRNewswire/ -- In nine best-selling editions, Shara Rosen (MBA, RT), has created authoritative market estimates and forecasted growth models for in vitro diagnostic (IVD) testing products throughout the world. This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a tremendous value.

Used by Top IVD Companies For Business Planning.

This year, Kalorama has published its ninth edition of this informative volume based on the market events of 2013 and early 2014. New entrants, new technologies have entered the stage and all important events are cataloged in this report. The idea behind Kalorama's unique report is that the entire market can be captured in one volume. Published every two years, this volume includes market estimates for 2013 base year and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including:
Core Lab (General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
Point of Care (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
Histology and Cytology (Pap, ISH, IHC, HPV)
Lab-based Infectious Disease Immunoassays, by Test (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
Hematology
Molecular Test Sales, Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others
Lab-based Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
Coagulation (Lab-Based, POC, Genetic Markers)
Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an IVD industry veteran, who has tracked hundreds of companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the industry as it is in 2014. The report includes data in a sizeable number of IVD segments and detailed discussion of the trends that are impacting the industry. The report also provides a realistic forecast five years into the future for companies already participating in or considering entry into this growing industry.

Independent Perspective. Authoritative Coverage.

At 1200 pages, this is the most comprehensive report on the in vitro diagnostic industry available. No surprise that it has been called the 'Bible of the IVD Industry' by past users of the report. Many of the top IVD companies use this product for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments.

Understand areas of the market that might not be available in your company's internal resources. View the industry from an independent point of view. Learn about competitors in a way that may be invisible to internal personnel. Know the market players - your potential partners, your existing or potential competitors, in proper context. Save countless hours of staff time and other research expenses with the authoritative guide for IVD market estimates and forecasts.

Worldwide Coverage, Including Emerging Markets.

From the first edition, this report has been intended to create a global picture for readers. Clinical testing is a worldwide business. This has always been true, but today emerging markets are part of the growth strategy of companies large and small. Kalorama has adjusted to these industry trends with enhanced geographic segmentation. While the US is a large healthcare market, many of the most interesting opportunities for companies are occurring in emerging markets.

As part of its coverage, the report breaks down the entire IVD market for the following regions:
North America
Europe (with total IVD market sizes for EU countries)
Asia (China, Japan, India)
Latin America
Rest of World
Not Just "What" Happened in the Industry, But "Why?"

The report does not merely report figures absent context. It describes the competitive workings of the diagnostics industry, combining a competitor, product, regulatory and payor decision analysis. In addition to providing authoritative market estimates for IVD market segments, this unique report seeks to explain why market events are occurring. The report delves into fast- breaking trends in in vitro diagnostics and distinguishes between company PR and actual market reality.

As part of its coverage, the following trends are detailed in the report:
Sample to Insight: IT Makes It Possible
The Lure of IVD – Companies Mix and Match
Distribution Agreements
Emerging Market Growth
Licenses and Collaboration Agreements
Test Services Commercialization
Top Suppliers and Niche Players
Selected Test Innovations from Non-Commercial Facilities
Sequencing Moves To The Clinic
LDTs
Personalized Precision Medicine Advances and Barriers
LOCs Enable Mobile Health (mHealth)
Digital PCR
Exomes
Omics and BIG Data
Superior Company Profiling - Understand How Companies Rank and Where They Compete.

The report contains detailed profiles of the top players in IVD. Profiling in this report describes the developments in each significant division of their business. A number of secondary players are also extensively profiled, as well as specialty companies with expertise in one testing area.
Abbott Diagnostics
Alere Inc.
Arkray
Beckman Coulter, Inc.
Becton, Dickinson and Company (BD)
bioMérieux Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Hologic, Inc.
Ortho Clinical Diagnostics (OCD)
QIAGEN N.V.
Siemens Healthcare Diagnostics
Sysmex Corporation
Thermo Fisher Scientific Inc.
Affymetrix Inc.
Cepheid
Eiken Chemical Co., Ltd
ERBA Diagnostics, Inc.
DiaSorin S.p.A
Fujirebio Diagnostics, Inc.
Illumina
LabCorp
Luminex Corporation
Menarini Diagnostics
Myriad Genetics
PerkinElmer, Inc. (PE)
Quest Diagnostics
Quidel Corporation
Randox Laboratories Ltd.
TOSOH Corporation
Wako Pure Chemical Industries
And hundreds of other companies...
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data for the in vitro diagnostic market are presented in U.S. dollar market size for categories of tests, and for specific analytes where possible. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.

The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the IVD industry.
Download the full report: https://www.reportbuyer.com/product/2357766/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com